1. Home
  2. VLRS vs KROS Comparison

VLRS vs KROS Comparison

Compare VLRS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • KROS
  • Stock Information
  • Founded
  • VLRS 2005
  • KROS 2015
  • Country
  • VLRS Mexico
  • KROS United States
  • Employees
  • VLRS N/A
  • KROS N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLRS Consumer Discretionary
  • KROS Health Care
  • Exchange
  • VLRS Nasdaq
  • KROS Nasdaq
  • Market Cap
  • VLRS 546.3M
  • KROS 558.9M
  • IPO Year
  • VLRS N/A
  • KROS 2020
  • Fundamental
  • Price
  • VLRS $4.94
  • KROS $14.53
  • Analyst Decision
  • VLRS Strong Buy
  • KROS Buy
  • Analyst Count
  • VLRS 6
  • KROS 13
  • Target Price
  • VLRS $8.35
  • KROS $20.63
  • AVG Volume (30 Days)
  • VLRS 809.4K
  • KROS 477.3K
  • Earning Date
  • VLRS 07-21-2025
  • KROS 08-06-2025
  • Dividend Yield
  • VLRS N/A
  • KROS N/A
  • EPS Growth
  • VLRS N/A
  • KROS N/A
  • EPS
  • VLRS 0.04
  • KROS 0.11
  • Revenue
  • VLRS $3,052,207,000.00
  • KROS $214,713,000.00
  • Revenue This Year
  • VLRS $2.04
  • KROS $5,006.76
  • Revenue Next Year
  • VLRS $12.38
  • KROS N/A
  • P/E Ratio
  • VLRS $13.34
  • KROS $132.80
  • Revenue Growth
  • VLRS N/A
  • KROS 91657.70
  • 52 Week Low
  • VLRS $3.49
  • KROS $9.12
  • 52 Week High
  • VLRS $9.00
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 59.60
  • KROS 64.67
  • Support Level
  • VLRS $4.35
  • KROS $13.26
  • Resistance Level
  • VLRS $4.46
  • KROS $14.68
  • Average True Range (ATR)
  • VLRS 0.21
  • KROS 0.41
  • MACD
  • VLRS 0.02
  • KROS 0.12
  • Stochastic Oscillator
  • VLRS 98.75
  • KROS 89.35

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: